Invention Grant
- Patent Title: Imidazo-, pyrazolopyrazines and imidazotriazines and their use
-
Application No.: US13905480Application Date: 2013-05-30
-
Publication No.: US09434731B2Publication Date: 2016-09-06
- Inventor: Stephan Siegel , Andreas Wilmen , Susanne Röhrig , Niels Svenstrup , Mark Jean Gnoth , Stefan Heitmeier , Ulrich Rester , Adrian Tersteegen , Michael Gerisch
- Applicant: Bayer Intellectual Property GmbH
- Applicant Address: DE Monheim
- Assignee: Bayer Intellectual Property GmbH
- Current Assignee: Bayer Intellectual Property GmbH
- Current Assignee Address: DE Monheim
- Priority: DE102007032349 20070711
- Main IPC: A61K31/535
- IPC: A61K31/535 ; C07D487/04 ; C12N5/0789
Abstract:
The invention relates to substituted imidazo-, pyrazolopyrazines and imidazotriazines and processes for their preparation, and their use for the manufacture of medicaments for the treatment and/or prophylaxis of diseases, in particular of hematological disorders, preferably of leukopenias and neutropenias.
Public/Granted literature
- US20130261115A1 IMIDAZO-, PYRAZOLOPYRAZINES AND IMIDAZOTRIAZINES AND THEIR USE Public/Granted day:2013-10-03
Information query
